EV/EBITDA
-0.10
+0.14+58.33%
55 min ago
Summary
- As of March 10, 2025, ALGS EV/EBITDA is -0.10, with a rise of +0.14 (+58.33%) during the most recent trading day.
- Over the past year, ALGS EV/EBITDA has dropped by -0.82 (-113.89%).
- ALGS EV/EBITDA is now -111.11% below its all-time high of 0.90.
Performance
ALGS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALGS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +58.3% | -56.1% | -25.4% |
| 1 m1 month | +88.0% | -87.6% | -65.2% |
| 3 m3 months | +89.1% | -88.8% | -67.8% |
| 6 m6 months | +9.1% | -5.1% | -29.7% |
| ytdytd | +91.7% | -91.4% | -73.9% |
| 1 y1 year | -113.9% | +115.6% | -52.6% |
| 5 y5 years | - | - | - |
ALGS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.83 | +88.0% | |
| 3 m | 3-month | -0.10 | at high | -1.53 | +93.5% |
| 6 m | 6-month | 0.11 | -190.9% | -1.53 | +93.5% |
| 1 y | 1-year | 0.72 | -113.9% | -1.53 | +93.5% |
| 3 y | 3-year | 0.90 | -111.1% | -1.53 | +93.5% |
| 5 y | 5-year | 0.90 | -111.1% | -15.58 | +99.4% |
| alltime | all time | 0.90 | -111.1% | -15.58 | +99.4% |
Aligos Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.10(-91.7%) |
| 2024 | -1.20(-236.4%) |
| 2023 | 0.88(+193.3%) |
| Date | Value |
|---|---|
| 2022 | 0.30(-111.2%) |
| 2021 | -2.68(-68.5%) |
| 2020 | -8.51 |
FAQ
- What is Aligos Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aligos Therapeutics?
- What is ALGS EV/EBITDA year-to-date change?
- What is Aligos Therapeutics EV/EBITDA year-on-year change?
What is Aligos Therapeutics EV/EBITDA?
The current EV/EBITDA of ALGS is -0.10
What is the all time high EV/EBITDA for Aligos Therapeutics?
Aligos Therapeutics all-time high EV/EBITDA is 0.90
What is ALGS EV/EBITDA year-to-date change?
Aligos Therapeutics EV/EBITDA has changed by +1.10 (+91.67%) since the beginning of the year
What is Aligos Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALGS EV/EBITDA has changed by -0.82 (-113.89%)